![](/img/cover-not-exists.png)
P061 - Reduction in extraintestinal manifestations of Crohn's disease is associated with improvements in patient-reported and disease activity outcomes in patients treated with adalimumab
Reinisch, W., Lofberg, R., Louis, E., Yu, A.P., McHale, J., Beaulieu, N., Mulani, P., Chao, J.Volume:
3
Year:
2009
Language:
english
DOI:
10.1016/S1873-9946(09)60088-X
File:
PDF, 48 KB
english, 2009